Terns Pharmaceuticals, Inc.
General Counsel
2024-07-29–present
Elona Kogan, Esq.
General Counsel
Terns Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Elona Kogan, Esq.
Elona Kogan, Esq. is recorded as General Counsel at Terns Pharmaceuticals, Inc.. Terns Pharmaceuticals, Inc. reported in an 8-K filed July 29, 2024 that Elona Kogan, Esq. was appointed Chief Legal Officer, effective July 29, 2024.
“Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced the appointment of Elona Kogan, Esq., as chief legal officer, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Terns Pharmaceuticals, Inc.
General Counsel
SEC 8-K
Current2024-07-29–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.